These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 26606447)

  • 1. DNA-AuNP networks on cell membranes as a protective barrier to inhibit viral attachment, entry and budding.
    Li CM; Zheng LL; Yang XX; Wan XY; Wu WB; Zhen SJ; Li YF; Luo LF; Huang CZ
    Biomaterials; 2016 Jan; 77():216-26. PubMed ID: 26606447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liu-He-Tang inhibited plaque formation by human respiratory syncytial virus infection in cell lines of the human respiratory tract.
    Chang JS; Wang KC; Shieh DE; Chiang LC
    J Ethnopharmacol; 2011 Oct; 137(3):1149-55. PubMed ID: 21810459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surfactin Inhibits Membrane Fusion during Invasion of Epithelial Cells by Enveloped Viruses.
    Yuan L; Zhang S; Wang Y; Li Y; Wang X; Yang Q
    J Virol; 2018 Nov; 92(21):. PubMed ID: 30068648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Water extract of Cinnamomum cassia Blume inhibited human respiratory syncytial virus by preventing viral attachment, internalization, and syncytium formation.
    Yeh CF; Chang JS; Wang KC; Shieh DE; Chiang LC
    J Ethnopharmacol; 2013 May; 147(2):321-6. PubMed ID: 23518419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of DNA-AuNP networks on cell membranes and real-time movies for viral infection.
    Li C; Zheng L; Yang X; Wan X; Wu W; Zhen S; Li Y; Luo L; Huang C
    Data Brief; 2016 Mar; 6():652-60. PubMed ID: 26909382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ge-Gen-Tang has anti-viral activity against human respiratory syncytial virus in human respiratory tract cell lines.
    Chang JS; Wang KC; Shieh DE; Hsu FF; Chiang LC
    J Ethnopharmacol; 2012 Jan; 139(1):305-10. PubMed ID: 22120014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mechanistic paradigm for broad-spectrum antivirals that target virus-cell fusion.
    Vigant F; Lee J; Hollmann A; Tanner LB; Akyol Ataman Z; Yun T; Shui G; Aguilar HC; Zhang D; Meriwether D; Roman-Sosa G; Robinson LR; Juelich TL; Buczkowski H; Chou S; Castanho MA; Wolf MC; Smith JK; Banyard A; Kielian M; Reddy S; Wenk MR; Selke M; Santos NC; Freiberg AN; Jung ME; Lee B
    PLoS Pathog; 2013; 9(4):e1003297. PubMed ID: 23637597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Xiao-Qing-Long-Tang (Sho-seiryu-to) inhibited cytopathic effect of human respiratory syncytial virus in cell lines of human respiratory tract.
    Chang JS; Yeh CF; Wang KC; Shieh DE; Yen MH; Chiang LC
    J Ethnopharmacol; 2013 May; 147(2):481-7. PubMed ID: 23542148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly sulfated K5 Escherichia coli polysaccharide derivatives inhibit respiratory syncytial virus infectivity in cell lines and human tracheal-bronchial histocultures.
    Cagno V; Donalisio M; Civra A; Volante M; Veccelli E; Oreste P; Rusnati M; Lembo D
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4782-94. PubMed ID: 24914125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Clotrimazole Derivatives as Specific Inhibitors of Arenavirus Fusion.
    Torriani G; Trofimenko E; Mayor J; Fedeli C; Moreno H; Michel S; Heulot M; Chevalier N; Zimmer G; Shrestha N; Plattet P; Engler O; Rothenberger S; Widmann C; Kunz S
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30626681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The compound DATEM inhibits respiratory syncytial virus fusion activity with epithelial cells.
    Ohki S; Liu JZ; Schaller J; Welliver RC
    Antiviral Res; 2003 Apr; 58(2):115-24. PubMed ID: 12742571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A generic screening platform for inhibitors of virus induced cell fusion using cellular electrical impedance.
    Watterson D; Robinson J; Chappell KJ; Butler MS; Edwards DJ; Fry SR; Bermingham IM; Cooper MA; Young PR
    Sci Rep; 2016 Mar; 6():22791. PubMed ID: 26976324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obatoclax Inhibits Alphavirus Membrane Fusion by Neutralizing the Acidic Environment of Endocytic Compartments.
    Varghese FS; Rausalu K; Hakanen M; Saul S; Kümmerer BM; Susi P; Merits A; Ahola T
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27993855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral effect of 25-hydroxycholesterol against porcine reproductive and respiratory syndrome virus in vitro.
    Dong H; Zhou L; Ge X; Guo X; Han J; Yang H
    Antivir Ther; 2018; 23(5):395-404. PubMed ID: 29561734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanobodies® specific for respiratory syncytial virus fusion protein protect against infection by inhibition of fusion.
    Schepens B; Ibañez LI; De Baets S; Hultberg A; Bogaert P; De Bleser P; Vervalle F; Verrips T; Melero J; Vandevelde W; Vanlandschoot P; Saelens X
    J Infect Dis; 2011 Dec; 204(11):1692-701. PubMed ID: 21998474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and Characterization of a Novel Broad-Spectrum Virus Entry Inhibitor.
    Chou YY; Cuevas C; Carocci M; Stubbs SH; Ma M; Cureton DK; Chao L; Evesson F; He K; Yang PL; Whelan SP; Ross SR; Kirchhausen T; Gaudin R
    J Virol; 2016 May; 90(9):4494-4510. PubMed ID: 26912630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Labyrinthopeptins as virolytic inhibitors of respiratory syncytial virus cell entry.
    Blockus S; Sake SM; Wetzke M; Grethe C; Graalmann T; Pils M; Le Goffic R; Galloux M; Prochnow H; Rox K; Hüttel S; Rupcic Z; Wiegmann B; Dijkman R; Rameix-Welti MA; Eléouët JF; Duprex WP; Thiel V; Hansen G; Brönstrup M; Haid S; Pietschmann T
    Antiviral Res; 2020 May; 177():104774. PubMed ID: 32197980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GS-5806 Inhibits a Broad Range of Respiratory Syncytial Virus Clinical Isolates by Blocking the Virus-Cell Fusion Process.
    Perron M; Stray K; Kinkade A; Theodore D; Lee G; Eisenberg E; Sangi M; Gilbert BE; Jordan R; Piedra PA; Toms GL; Mackman R; Cihlar T
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1264-73. PubMed ID: 26666922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Replication-Competent Influenza Virus and Respiratory Syncytial Virus Luciferase Reporter Strains Engineered for Co-Infections Identify Antiviral Compounds in Combination Screens.
    Yan D; Weisshaar M; Lamb K; Chung HK; Lin MZ; Plemper RK
    Biochemistry; 2015 Sep; 54(36):5589-604. PubMed ID: 26307636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Yakammaoto inhibited human coxsackievirus B4 (CVB4)-induced airway and renal tubular injuries by preventing viral attachment, internalization, and replication.
    Yen MH; Lee JJ; Yeh CF; Wang KC; Chiang YW; Chiang LC; Chang JS
    J Ethnopharmacol; 2014 Feb; 151(3):1056-1063. PubMed ID: 24361333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.